Richard Toselli is the founder of InVivo Therapeutics. Latest round: Growth. Backed by Lincoln Park Capital Fund. Based in Cambridge, MA.
Richard Toselli, M.D., is the President, CEO, and Chief Medical Officer of InVivo Therapeutics, a clinical-stage biotechnology company focused on spinal cord injury treatments. He was first appointed as Chief Medical Officer in July 2017 before becoming president and CEO shortly thereafter. Toselli also serves as a Director on the company's board.
Full founder directory · Investor directory · Company funding database · Fundraising library